Osaic Holdings’s Kymera Therapeutics KYMR Stock Holding History

Osaic Holdings’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$95.7K	Buy	835 +376	+82%	+$32.3K	﹤0.01%	4986
2026 Q1	$38.2K	Sell	459 -922	-67%	-$73K	﹤0.01%	5412
2025 Q4	$107K	Buy	1,381 +71	+5%	+$4.79K	﹤0.01%	4645
2025 Q3	$76K	Buy	1,310 +221	+20%	+$9.97K	﹤0.01%	5014
2025 Q2	$47.5K	Buy	1,089 +1,083	+18,050%	+$37.3K	﹤0.01%	5090
2025 Q1	$164	Sell	6 -56	-90%	-$2.04K	﹤0.01%	7191
2024 Q4	$2.49K	Sell	62 -12,092	-99%	-$546K	﹤0.01%	6520
2024 Q3	$575K	Buy	12,154 +12,006	+8,112%	+$530K	﹤0.01%	2735
2024 Q2	$4.42K	Buy	+148	New	+$5.12K	﹤0.01%	6237
2023 Q4	–	Sell	-300	Closed	-$4.17K	–	7391
2023 Q3	$4.17K	Hold	300	–	–	﹤0.01%	6350
2023 Q2	$6.9K	Sell	300 -2,350	-89%	-$67.3K	﹤0.01%	6160
2023 Q1	$78.5K	Hold	2,650	–	–	﹤0.01%	4633
2022 Q4	$66K	Hold	2,650	–	–	﹤0.01%	4737
2022 Q3	$57K	Buy	+2,650	New	+$69.8K	﹤0.01%	4805

Other funds holding KYMR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Osaic Holdings's KYMR Position: Q2 2026 in Review

Osaic Holdings increased its Kymera Therapeutics (KYMR) stake by 82% in Q2 2026, buying an estimated $32.3K and bringing the position to 835 shares worth $95.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4986.

Osaic Holdings first reported a position in KYMR in Q3 2022 and has held it in 14 quarters since. The position peaked at $575K in Q3 2024. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

Osaic Holdings held 835 shares of Kymera Therapeutics worth $95.7K as of Q2 2026.
Osaic Holdings bought 376 Kymera Therapeutics shares in Q2 2026, an estimated $32.3K.
Kymera Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4986 holding.
Osaic Holdings first reported a position in Kymera Therapeutics in Q3 2022 and has held it in 14 quarters since.
Osaic Holdings's Kymera Therapeutics position peaked at $575K in Q3 2024.
276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.